EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stereoselective targeting with chiral nanomaterials: A strategy for precision therapy in neurodegenerative diseases

Ruhui Luo, Yaqing Zhang, Xiner Tan, Longquan Shao

Acta Biomaterialia · 2026-06 · 217 · 503-529

DOI: 10.1016/j.actbio.2026.05.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Ruhui Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital Zhejiang University, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Nanostructures, Nanoparticles, Nanomedicine. Die Arbeit nennt 206 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenge in treating neurodegenerative diseases (NDs) lies in the complexity of their pathological mechanisms. Strategies capable of synergistically regulating multiple pathological features are crucial for treating NDs. Chiral nanomaterials (CNMs), including chiral nanoparticles (CNPs) and chiral nanoassemblies (CAMs), offer a unique platform for achieving such precise multitarget regulation because of their stereoselective interactions. Strategies for synthesizing CNMs are outlined in this review, and an in-depth analysis of their core biological mechanisms for treating NDs-inhibiting and clearing pathological proteins, enhancing synaptic plasticity, alleviating neuroinflammation, selectively eliminating senescent cells and promoting the differentiation of neural stem cells-is provided. Optimization of these functions through internal chiral design and external physical field modulation is explored. Finally, we propose forward-looking concepts such as "stage-optimized chiral nanomedicines" and "intelligently responsive chiral nanomaterials" to provide guidance for next-generation precision nanomedicine for NDs. STATEMENT OF SIGNIFICANCE: The key challenge in treating neurodegenerative diseases (NDs) lies in the precise identification and coordinated regulation of multi-target pathological processes. In recent years, chiral nanomaterials (CNMs), including chiral nanoparticles (CNPs) and chiral nanoassemblies (CAMs), have emerged as innovative tools for NDs intervention owing to their unique stereoselective recognition capabilities. This review systematically categorizes CNMs and their synthesis strategies, and focuses on elucidating their core biological mechanisms, including the inhibition and clearance of pathological proteins, enhancement of synaptic plasticity, alleviation of neuroinflammation, selective elimination of senescent cells, and promotion of neural stem cell differentiation. Furthermore, strategies to optimize their functionality through internal chiral structure design and external physical field modulation are explored. Collectively, this review aims to systematically elucidate the biological mechanisms and material properties of CNMs in NDs therapy, providing a theoretical foundation and guidance for the rational design and construction of next-generation neurorepair materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesNanostructuresNanoparticlesNanomedicineHumansAnimalsStereoisomerismNeural Stem Cells

Stichwörter der Autor:innen

Chiral nanoassembliesChiral nanomaterialsChiral nanoparticlesChiralityNeurodegenerative diseasesStereoselectivity

Autor:innen und Institutionen

  • The Second Affiliated Hospital Zhejiang University, Hangzhou, 310009, China.
  • Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510280, China.
  • Hospital of stomatology, Zhongshan, 528400, China.
  • Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510280, China; Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Guangzhou 510515, China. El…

Zitieren

APA

Luo, R., Zhang, Y., Tan, X., & Shao, L. (2026). Stereoselective targeting with chiral nanomaterials: A strategy for precision therapy in neurodegenerative diseases. Acta Biomaterialia, 217, 503-529. https://doi.org/10.1016/j.actbio.2026.05.021

Vancouver

Luo R, Zhang Y, Tan X, Shao L. Stereoselective targeting with chiral nanomaterials: A strategy for precision therapy in neurodegenerative diseases. Acta Biomaterialia. 2026;217:503-529. doi:10.1016/j.actbio.2026.05.021

BibTeX
@article{Luo2026,
  author = {Luo, Ruhui and Zhang, Yaqing and Tan, Xiner and Shao, Longquan},
  title = {Stereoselective targeting with chiral nanomaterials: A strategy for precision therapy in neurodegenerative diseases},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {217},
  pages = {503--529},
  doi = {10.1016/j.actbio.2026.05.021}
}
Kostenlos starten →